Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Essential Amino Acid Supplementation for Femoral Fragility Fractures [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating essential amino acid supplementation for femoral fractures and fragility fractures, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Essential amino acid supplementation (essential amino acid supplementation)

Snippet

Sponsor: Michael C Willey | Conditions: Femoral Fracture, Fragility Fracture | Phase 2 | Status: RECRUITING